Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity

Neurochemistry International

Volumn 95, Issue , 2016, Pages 37-45

  Bollimpelli, V Satish ^a   Kumar, Prashant ^a   Kumari, Sonali ^a   Kondapi, Anand K ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Curcumin; Lactoferrin; Nano particle; Rotenone

Indexed keywords

ALPHA SYNUCLEIN; CURCUMIN; LACTOFERRIN; NANOPARTICLE; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; ROTENONE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL VIABILITY ASSAY; DOPAMINERGIC NERVE CELL; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HUMAN; HUMAN CELL; HYDRODYNAMICS; NANOENCAPSULATION; NEUROBLASTOMA CELL LINE; NEUROPROTECTION; NEUROTOXICITY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROFLUOROMETRY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; METABOLISM; PHYSIOLOGY; SYNTHESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DRUG COMPOUNDING; HUMANS; LACTOFERRIN; NANOPARTICLES; NEUROPROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; ROTENONE;

EID: 84962977224     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2016.01.006     Document Type: Article

References (39)

1. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818 http://www.ncbi.nlm.nih.gov/pubmed/17999464
2. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306 http://www.ncbi.nlm.nih.gov/pubmed/0011100151
3. R.S. Chaves, T.Q. Melo, S.A. Martins, and M.F. Ferrari Protein aggregation containing beta-amyloid, alpha-synuclein and hyperphosphorylated tau in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure BMC Neurosci. 11 2010 144 http://www.ncbi.nlm.nih.gov/pubmed/21067569
4. S.S. Davis Biomedical applications of nanotechnology-implications for drug targeting and gene therapy Trends Biotechnol. 15 1997 217 224 http://www.ncbi.nlm.nih.gov/pubmed/9183864
5. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822 http://www.ncbi.nlm.nih.gov/pubmed/14593166
6. S. Doggui, J.K. Sahni, M. Arseneault, L. Dao, and C. Ramassamy Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line J. Alzheimers Dis. 30 2012 377 392 http://www.ncbi.nlm.nih.gov/pubmed/22426019
7. B.A. Faucheux, N. Nillesse, P. Damier, G. Spik, A. Mouatt-Prigent, A. Pierce, B. Leveugle, N. Kubis, J.J. Hauw, Y. Agid, and et al. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease Proc. Natl. Acad. Sci. U. S. A. 92 1995 9603 9607 http://www.ncbi.nlm.nih.gov/pubmed/7568181
8. C. Fillebeen, L. Descamps, M.P. Dehouck, L. Fenart, M. Benaissa, G. Spik, R. Cecchelli, and A. Pierce Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier J. Biol. Chem. 274 1999 7011 7017 http://www.ncbi.nlm.nih.gov/pubmed/10066755
9. M. Ganguli, V. Chandra, M.I. Kamboh, J.M. Johnston, H.H. Dodge, B.K. Thelma, R.C. Juyal, R. Pandav, S.H. Belle, and S.T. DeKosky Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross-National Dementia study Arch. Neurol. 57 2000 824 830 http://www.ncbi.nlm.nih.gov/pubmed/10867779
10. M. Garcia-Alloza, L.A. Borrelli, A. Rozkalne, B.T. Hyman, and B.J. Bacskai Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model J. Neurochem. 102 2007 1095 1104 http://www.ncbi.nlm.nih.gov/pubmed/17472706
11. K. Golla, C. Bhaskar, F. Ahmed, and A.K. Kondapi A target-specific oral formulation of doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer J. Cancer 4 2013 644 652 http://www.ncbi.nlm.nih.gov/pubmed/24155776
12. S. Honary, and F. Zahir Effect of zeta potential on the properties of nano-drug delivery systems- a review (Part 1) Trop. J. Pharm. Res. 12 2013 255 264 http://www.ajol.info/index.php/tjpr/article/view/88554
13. R. Huang, L. Han, J. Li, F. Ren, W. Ke, C. Jiang, and Y. Pei Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles J. Gene Med. 11 2009 754 763 http://www.ncbi.nlm.nih.gov/pubmed/19554623
14. O. Hwang Role of oxidative stress in Parkinson's disease Exp. Neurobiol. 22 2013 11 17 http://www.ncbi.nlm.nih.gov/pubmed/23585717
15. S.J. Kim, T.G. Son, H.R. Park, M. Park, M.S. Kim, H.S. Kim, H.Y. Chung, M.P. Mattson, and J. Lee Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus J. Biol. Chem. 283 2008 14497 14505 http://www.ncbi.nlm.nih.gov/pubmed/18362141
16. A.D. Krishna, R.K. Mandraju, G. Kishore, and A.K. Kondapi An efficient targeted drug delivery through apotransferrin loaded nanoparticles PLoS One 4 2009 e7240 http://www.ncbi.nlm.nih.gov/pubmed/19806207
17. R. Kuttan, P. Bhanumathy, K. Nirmala, and M.C. George Potential anticancer activity of turmeric (Curcuma longa) Cancer Lett. 29 1985 197 202 http://www.ncbi.nlm.nih.gov/pubmed/4075289
18. A.E. Lang, and A.M. Lozano Parkinson's disease. First of two parts N. Engl. J. Med. 339 1998 1044 1053 http://www.ncbi.nlm.nih.gov/pubmed/9761807
19. L. Li, F.S. Braiteh, and R. Kurzrock Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis Cancer 104 2005 1322 1331 http://www.ncbi.nlm.nih.gov/pubmed/16092118
20. N. Li, K. Ragheb, G. Lawler, J. Sturgis, B. Rajwa, J.A. Melendez, and J.P. Robinson Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production J. Biol. Chem. 278 2003 8516 8525 http://www.ncbi.nlm.nih.gov/pubmed/12496265
21. Z. Liu, T. Li, D. Yang, and W.,W. Smith Curcumin protects against rotenone induced neurotoxicity in cell and drosophila models of Parkinson's disease Adv. Parkinson's Dis. 2 2013 18 27 http://file.scirp.org/Html/4-2620009-27827.htm
22. Z. Liu, Y. Yu, X. Li, C.A. Ross, and W.W. Smith Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism Pharmacol. Res. 63 2011 439 444 http://www.ncbi.nlm.nih.gov/pubmed/21237271
23. G.B. Mahady, S.L. Pendland, G. Yun, and Z.Z. Lu Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen Anticancer Res. 22 2002 4179 4181 http://www.ncbi.nlm.nih.gov/pubmed/12553052
24. J.M. Miyasaki, W. Martin, O. Suchowersky, W.J. Weiner, and A.E. Lang Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality standards subcommittee of the American Academy of Neurology Neurology 58 2002 11 17 http://www.ncbi.nlm.nih.gov/pubmed/11781398
25. Tim Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 http://www.ncbi.nlm.nih.gov/pubmed/6606682
26. R.B. Mythri, and M.M. Bharath Curcumin: a potential neuroprotective agent in Parkinson's disease Curr. Pharm. Des. 18 2012 91 99 http://www.ncbi.nlm.nih.gov/pubmed/22211691
27. R.B. Mythri, G. Harish, S.K. Dubey, K. Misra, and M.M. Bharath Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson's disease Mol. Cell Biochem. 347 2011 135 143 http://www.ncbi.nlm.nih.gov/pubmed/20972609
28. C.W. Olanow, R.L. Watts, and W.C. Koller An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines Neurology 56 2001 S1 S88 http://www.ncbi.nlm.nih.gov/pubmed/11402154
29. S. Padhye, D. Chavan, S. Pandey, J. Deshpande, K.V. Swamy, and F.H. Sarkar Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry Mini Rev. Med. Chem. 10 2010 372 387 http://www.ncbi.nlm.nih.gov/pubmed/20370702
30. S. Prasad, A.K. Tyagi, and B.B. Aggarwal Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice Cancer Res. Treat. 46 2014 2 18 http://www.ncbi.nlm.nih.gov/pubmed/24520218
31. A. Rajeswari Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Eur. Rev. Med. Pharmacol. Sci. 10 2006 157 161 http://www.ncbi.nlm.nih.gov/pubmed/16910344
32. O.P. Sharma Antioxidant activity of curcumin and related compounds Biochem. Pharmacol. 25 1976 1811 1812 http://www.ncbi.nlm.nih.gov/pubmed/942483
33. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P.S. Srinivas Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Med. 64 1998 353 356 http://www.ncbi.nlm.nih.gov/pubmed/9619120
34. G. Sonavane, K. Tomoda, and K. Makino Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size Colloids Surf. B Biointerfaces 66 2008 274 280 http://www.ncbi.nlm.nih.gov/pubmed/18722754
35. R.C. Srimal, and B.N. Dhawan Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent J. Pharm. Pharmacol. 25 1973 447 452 http://www.ncbi.nlm.nih.gov/pubmed/4146582
36. O. Vajragupta, P. Boonchoong, H. Watanabe, M. Tohda, N. Kummasud, and Y. Sumanont Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity Free Radic. Biol. Med. 35 2003 1632 1644 http://www.ncbi.nlm.nih.gov/pubmed/14680686
37. M.S. Wang, S. Boddapati, S. Emadi, and M.R. Sierks Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model BMC Neurosci. 11 2010 57 http://www.ncbi.nlm.nih.gov/pubmed/19464433
38. E. Wisse, and De, A, M. Leeuw Structural elements determining transport and exchange process in the liver S.S. Davis, L. Illum, J.G. McVie, E. Tomlinson, Microspheres and Drug Therapy, Pharmaceutical, Immunological and Medical Aspects 1984 Elsevier Amsterdam 1 23
39. Y. Xu, B. Ku, L. Cui, X. Li, P.A. Barish, T.C. Foster, and W.O. Ogle Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats Brain Res. 1162 2007 9 18 http://www.ncbi.nlm.nih.gov/pubmed/17617388